47
Views
4
CrossRef citations to date
0
Altmetric
Article

Protection against liver injury by PGE1 or anti‐TNF‐α is associated with a reduction of TNF‐R1 expression in hepatocytes

, , &
Pages 1169-1175 | Received 05 Jun 2003, Accepted 19 Aug 2003, Published online: 08 Jul 2009

References

  • Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666–70.
  • Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annu Rev Biochem 1988; 57:505–18.
  • Tartaglia LA, Rothe M, Hu YF, Goeddel DV. Tumor necrosis factor’s cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213–6.
  • Abe Y, Gatanaga M, Osuka Y, Kimura S, Burger RA, Granger GA, et al. Role of 55-and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol 1993;150:5070–9.
  • Menegazzi R, Cramer R, Patriarca P, Scheurich P, Dri P. Evidence that tumor necrosis factor« (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood 1994;84: 287–93.
  • Rothe J, Lesslauer W, Lötscher H, Lang Y, Köebel P, Kontgen F, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364: 798–802.
  • Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R, et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 1991;147:4229–38.
  • Heller RA, Song K, Fan N, Chang DJ. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992;70:47–56.
  • Dri P, Haas E, Cramer R, Menegazzi R, Gasparini Ch, Martinelli R, et al. Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophil respiratory burst. J Immunol 1999;162: 460–6.
  • Volpes R, Van den Oord JJ, De Vos R, Desmet VJ. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 1992;14:361–9.
  • Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 533–6.
  • Zylberberg H, Rimaniol A, Pol S, Masson A, De Groote D, Barthelot P, et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 1999;30:185–91.
  • Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845–9.
  • Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J Exp Med 1992;175:323–9.
  • Muntané J, Rodríguez FJ, Segado O, Quintero A, Lozano JM, Siendones E, et al. TNF-α-dependent production of inducible nitric oxide is involved in PGE1 protection against acute liver injury. Gut 2000;47:553–62.
  • Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869–71.
  • Bemelmans MHA, Greve JWM, Gouma DJ, Buurman WA. Increased concentrations of tumor necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 1996;38: 447–53.
  • Kozaki K, Egawa H, Bermudez L, Keefe EB, So SK, Esquivel CO. Effect of pentoxifylline pretreatment on kupffer cells in rat liver preservation. Hepatology 1995;21:1079–82.
  • Michie HR, Manogue KR, Spriggs DR, Revhaug A, O’Dwyer S, Dinarello CA, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481–6.
  • González-Amaro R, García Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yagüe E, et al. Induction of tumor necrosis factorα production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841–8.
  • Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M, Wakita T, et al. Immunohistochemical studies of intrahepatic tumour necrosis factor α in chronic liver diseases. J Clin Pathol 1990;43: 298–302.
  • Libert C, Van Bladel S, Brouckaert P, Shaw A, Fiers W. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J Immunol 1991;146:2625–32.
  • Abe Y, Watanabe Y, Kimura S. The role oftumor necrosis factor receptor in cell signalling and the significance of soluble form levels in the serum. Surg Jpn 1994;24:197–202.
  • Naveau S, Emilie D, Balian A, Grangeot-Keros L, Borotto E, Portier A, et al. Plasma levels of soluble TNF receptors p55 and p75 in patients with alcoholic liver disease of increasing severity. J Hepatol 1998;28: 778–84.
  • Marinos G, Naoumov NV, Rossol S, Torre F, Wong PYN, Gallati H, et al. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 1995;108:1453–63.
  • Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307–16.
  • Higuchi M, Aggarwal BB. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. J Biol Chem 1992; 267:20892–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.